Apomorphine effects on the hippocampus

被引:0
作者
Luis Enrique ArroyoGarca [1 ]
Antonio RodrguezMoreno [2 ]
Gonzalo Flores [1 ]
机构
[1] Laboratorio de Neuropsiquiatría, Instituto de Fisiología, Benemérita Universidad Autónoma de Puebla
[2] Laboratorio de Neurociencia Celular y Plasticidad, Universidad Pablo de Olavide
关键词
dopamine receptor; apomorphine; hippocampus; learning and memory; plasticity; dendritic length; oxidative stress; Parkinson’s disease;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
Apomorphine is a non-specific dopamine receptor agonist that has been used in the treatment of some diseases and mental disorders. Its use has particularly well documented in Parkinson's disease(PD). The dopaminergic agonists like apomorphine are related to oxidative processes that could induce cell damage and the functional impairment of some structures in the brain. However, most information about apomorphine in literature is focused on the improvement of the motor problems characteristic of PD, but little is known about the effects on cognitive behaviors and brain structures indirectly related to motor function. The presence of dopaminergic receptors in the hippocampus has recently been discovered, in connection with cognitive behaviors like learning and memory, these receptors are needed in neuronal plasticity. There has been a growing interest to know if this structure could be compromised by the effect of apomorphine and elucidate if part of the cognitive impairment present in the PD is due to the effect of apomorphine. In this mini-review, we summarized how apomorphine has been used since its creation, we discuss the latest information about its effect on the hippocampus and also the future perspectives to fully understand the effects of this compound.
引用
收藏
页码:2064 / 2066
页数:3
相关论文
共 19 条
[1]   Nitric oxide modulates apomorphine-induced recognition memory deficits in rats [J].
Gourgiotis, Ioannis ;
Kampouri, Nikoletta G. ;
Koulouri, Vasiliki ;
Lempesis, Ioannis G. ;
Prasinou, Maria D. ;
Georgiadou, Georgia ;
Pitsikas, Nikolaos .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2012, 102 (04) :507-514
[2]  
Apomorphine-pharmacological properties and clinical trials in Parkinson’’s disease. Jenner P,Katzenschlager R. Parkinsonism and Related Disorders . 2016
[3]  
Gender differences in Parkinson’’s disease:A clinical perspective. Georgiev D,Hamberg K,Hariz M,Forsgren L,Hariz GM. Acta Neurologica Scandinavica . 2017
[4]  
Pharmacological insights into the use of apomorphine in Parkinson’’s disease:clinical relevance. Auffret M,Drapier S,Vérin M. Clin Drug Investig . 2018
[5]  
Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase–polymerase chain reaction and autoradiography[J] .  &nbspNeuroscience . 1999 (2)
[6]   Strain differences of dopamine receptor levels and dopamine related behaviors in rats [J].
Zamudio, S ;
Fregoso, T ;
Miranda, A ;
De La Cruz, F ;
Flores, G .
BRAIN RESEARCH BULLETIN, 2005, 65 (04) :339-347
[7]  
Inhibition of apomorphine-induced behavioral sensitization in rats pretreated with fluoxetine[J] . Darakhshan J. Haleem,Muhammad Farhan. &nbspBehavioural Pharmacology . 2015 (1 an)
[8]  
Dopamine D1/D5 receptors in the dorsal hippocampus are required for the acquisition and expression of a single trial cocaine-associated memory[J] . Cecilia P. Kramar,M. Flavia Barbano,Jorge H Medina. &nbspNeurobiology of Learning and Memory . 2014
[9]  
Presynaptic D2 Dopamine Receptors Control LTD Expression and Memory Processes in the Temporal Hippocampus[J] . Jill Rocchetti,Elsa Isingrini,Gregory Dal Bo,Sara Sagheby,Aurore Menegaux,Fran?ois Tronche,Daniel Levesque,Luc Moquin,Alain Gratton,Tak Pan Wong,Marcelo Rubinstein,Bruno Giros. &nbspBiological Psychiatry . 2014
[10]  
The Pharmacological Properties and Therapeutic Use of Apomorphine. Samo Ribaric. Molecules . 2012